Related Experiment Video

Updated: Jul 29, 2025

Preparation of Myeloid Derived Suppressor Cells MDSC from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting AutoMACS
14:15

Preparation of Myeloid Derived Suppressor Cells MDSC from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting AutoMACS

Published on: June 18, 2012

26.3K

The role of myeloid-derived suppressor cells in liver cancer

Shiyue Zhou1,2, Zixuan Zhao1, Hao Zhong1

  • 1State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, Jinghai District, Tianjin, 301617, People's Republic of China.

Discover Oncology
|May 22, 2023
PubMed

Insights

Myeloid-derived suppressor cells (MDSCs) drive liver cancer progression by suppressing anti-tumor immunity. Targeting MDSCs offers a promising therapeutic strategy to enhance immunotherapy effectiveness for liver cancer patients.

Area of Science:

  • Immunology
  • Oncology
  • Hepatology

Background:

  • Myeloid-derived suppressor cells (MDSCs) are immature immune cells that accumulate in liver cancer.
  • MDSCs suppress anti-tumor immunity by inhibiting cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and dendritic cell (DC) antigen presentation, while promoting regulatory T cells (Tregs).
  • This immune suppression contributes to immune escape, treatment resistance, and liver cancer progression.

Purpose of the Study:

  • To review the role of MDSCs in the liver immune microenvironment and their mechanisms of action in liver cancer.
  • To explore current and emerging therapeutic strategies targeting MDSCs for enhancing anti-tumor immunity in liver cancer.
  • To provide insights into future directions for MDSC-targeted immunotherapy in liver cancer treatment.

Main Methods:

  • Literature review of preclinical and clinical studies on MDSCs in liver cancer.
  • Analysis of the functional mechanisms of MDSCs in modulating the liver tumor microenvironment.
  • Evaluation of therapeutic approaches targeting MDSCs, including monotherapy and combination strategies.

Main Results:

  • MDSCs play a critical role in promoting liver cancer progression by creating an immunosuppressive tumor microenvironment.
  • Targeting MDSCs has demonstrated encouraging results in preclinical models, both as standalone and combination therapies.
  • Strategies aimed at depleting or inhibiting MDSC function can restore anti-tumor immune responses.

Conclusions:

  • MDSCs are key regulators of immune evasion in liver cancer and represent a significant therapeutic target.
  • Targeting MDSCs holds substantial promise for improving the efficacy of immunotherapy in advanced liver cancer.
  • Further research into MDSC-targeted strategies is crucial for developing novel and effective liver cancer treatments.

More Related Videos

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity08:41

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity

Published on: June 7, 2017

8.3K
Isolation and Characterization of Neutrophils with Anti-Tumor Properties10:15

Isolation and Characterization of Neutrophils with Anti-Tumor Properties

Published on: June 19, 2015

24.9K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.4K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K